Clinical Trial Update: Evaluation of a Treatment With Allopurinol in Adenylosuccinate Lyase Deficiency [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating allopurinol for Adenylosuccinate Lyase Deficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenylosuccinate Lyase Deficiency

Drugs mentioned

• Allopurinol (Allopurinol)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Adenylosuccinate Lyase Deficiency | Phase 2 | Status: COMPLETED